FindTrial
Sign In

Study for the genetics factors of unexplained severe neonatal hyperbilirubinemia

Study for the genetics factors of unexplained severe neonatal hyperbilirubinemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020424
Enrollment
Unknown
Registered
2018-12-29
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal hyperbillirubinemia

Interventions

Case series:Nil

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) gestational age=35 weeks with postnatal age =7days; 2) the unconjugated bilirubin takes up major parts of the total bilirubin, the conjugated bilirubin accounts for =20% of total bilirubin; 3) the total serum bilirubin exceeds the exchanging transfusion criteria according to the expert consensus for neonatal hyperbilirubinemia diagnosis and treatment published in 2014.

Exclusion criteria

Exclusion criteria: the patients with culture-confirmed sepsis, multiple malformation, confirmed ABO hemolysis and G-6-PD.

Design outcomes

Primary

MeasureTime frame
total serum bilirubin;the genotype of SNPs in candidate genes;—

Secondary

MeasureTime frame
speed of total serum bilirubin drops;hospital stays;—

Countries

China

Contacts

Public ContactWang Jianhui

Children's Hospital of Chongqing Medical University

wangjh805@126.com+86 13678428167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026